Consistent with the viability results, Annexin V/propidium iodide (PI) staining analysis showed a significant increase of apoptosis at 24 and 48 h in B- and T-ALL cells proportional to drug dose and drug exposure times (Additional file 1: Figure S3-A). The gene discussed is ANXA5; the disease is acute lymphoblastic leukemia.